Steven Grant

Person

Ely, GB

People

Patents Grantslast 30 patents

Information Patent Grant
Compositions monovalent for CD28 binding and methods of use
- Patent number 12,012,452
- Issue date Jun 18, 2024
- Bristol-Myers Squibb Company
- Murray McKinnon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody polypeptides that antagonize CD40L
- Patent number 11,180,567
- Issue date Nov 23, 2021
- Bristol-Myers Squibb Company
- Steven G. Nadler
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of treating immune diseases by administering antibody polyp...
- Patent number 11,136,406
- Issue date Oct 5, 2021
- Bristol-Myers Squibb Company
- Anish Suri
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions monovalent for CD28 binding and methods of use
- Patent number 10,919,965
- Issue date Feb 16, 2021
- Bristol-Myers Squibb Company
- Murray McKinnon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acids encoding antibody polypeptides that antagonize CD40
- Patent number 10,544,228
- Issue date Jan 28, 2020
- Bristol-Myers Squibb Company
- Anish Suri
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating immune diseases by administering antibody polyp...
- Patent number 10,196,451
- Issue date Feb 5, 2019
- Bristol-Myers Squibb Company
- Steven G. Nadler
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions monovalent for CD28 binding and methods of use
- Patent number 9,908,937
- Issue date Mar 6, 2018
- Bristol-Myers Squibb Company
- Murray McKinnon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody polypeptides that antagonize CD40L
- Patent number 9,765,150
- Issue date Sep 19, 2017
- Bristol-Myers Squibb Company
- Steven G. Nadler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody polypeptides that antagonize CD40
- Patent number 9,475,879
- Issue date Oct 25, 2016
- Bristol-Myers Squibb Company
- Anish Suri
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody polypeptides that antagonize CD40L
- Patent number 9,228,018
- Issue date Jan 5, 2016
- Bristol-Myers Squibb Company
- Steven G. Nadler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti P2X7 receptor antibodies and fragments thereof
- Patent number 9,127,059
- Issue date Sep 8, 2015
- Biosceptre International Limited
- Julian Alexander Barden
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions monovalent for CD28 binding and methods of use
- Patent number 9,085,629
- Issue date Jul 21, 2015
- Bristol-Myers Squibb Company
- Murray McKinnon
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Nucleic acids encoding antibody polypeptides that antagonize CD40L
- Patent number 8,981,072
- Issue date Mar 17, 2015
- Bristol-Myers Squibb Company
- Steven G. Nadler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody polypeptides that antagonize CD40L
- Patent number 8,895,010
- Issue date Nov 25, 2014
- Bristol-Myers Squibb Company
- Steven G. Nadler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of antagonizing the binding of CD40 to CD40L with CD40L-spe...
- Patent number 8,524,236
- Issue date Sep 3, 2013
- Domantis Limited
- Steven Grant
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions monovalent for CD28 binding and methods of use
- Patent number 8,454,959
- Issue date Jun 4, 2013
- Bristol-Meyers Squibb Company
- Murray McKinnon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Dual-specific IL-1α/IL-1β antibodies
- Patent number 8,324,350
- Issue date Dec 4, 2012
- Abbott Laboratories
- Chung-ming Hsieh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions monovalent for CD28 binding and methods of use
- Patent number 8,168,759
- Issue date May 1, 2012
- Bristol-Myers Squibb Company
- Murray McKinnon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies against Candida antigens
- Patent number 8,092,800
- Issue date Jan 10, 2012
- Istituto Superiore di Sanita
- Antonio Cassone
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of antagonizing binding of CD40 to CD40L with CD40L-specifi...
- Patent number 7,927,596
- Issue date Apr 19, 2011
- Domantis Limited
- Steven Grant
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CD40L-specific monovalent polypeptides
- Patent number 7,829,096
- Issue date Nov 9, 2010
- Domantis Ltd.
- Steven Grant
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Monovalent anti-CD40L antibody polypeptides and compositions thereof
- Patent number 7,563,443
- Issue date Jul 21, 2009
- Domantis Limited
- Steven Grant
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L
- Publication number 20220073636
- Publication date Mar 10, 2022
- Bristol-Myers Squibb Company
- Steven G. NADLER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS MONOVALENT FOR CD28 BINDING AND METHODS OF USE
- Publication number 20210047414
- Publication date Feb 18, 2021
- Bristol-Myers Squibb Company
- Murray McKinnon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING IMMUNE DISEASES BY ADMINISTERING ANTIBODY POLY...
- Publication number 20200199244
- Publication date Jun 25, 2020
- Bristol-Myers Squibb Company
- Anish SURI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L
- Publication number 20190100595
- Publication date Apr 4, 2019
- Bristol-Myers Squibb Company
- Steven G. NADLER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L
- Publication number 20180051091
- Publication date Feb 22, 2018
- Bristol-Myers Squibb Company
- Steven G. NADLER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40
- Publication number 20170015754
- Publication date Jan 19, 2017
- Bristol-Myers Squibb Company
- Anish SURI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L
- Publication number 20160075790
- Publication date Mar 17, 2016
- Domantis Limited
- Steven G. NADLER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS MONOVALENT FOR CD28 BINDING AND METHODS OF USE
- Publication number 20150299321
- Publication date Oct 22, 2015
- Bristol-Myers Squibb Company
- Murray McKinnon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI P2X7 RECEPTOR ANTIBODIES AND FRAGMENTS THEREOF
- Publication number 20150266969
- Publication date Sep 24, 2015
- BIOSCEPTRE INTERNATIONAL LIMITED
- Julian Alexander Barden
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L
- Publication number 20150023976
- Publication date Jan 22, 2015
- Bristol -Myers Squibb Company
- Steven G. NADLER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L
- Publication number 20140099707
- Publication date Apr 10, 2014
- Domantis Limited
- Steven G. NADLER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40
- Publication number 20140099317
- Publication date Apr 10, 2014
- DOMANTIS LIMITED
- Anish Suri
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS MONOVALENT FOR CD28 BINDING AND METHODS OF USE
- Publication number 20130230540
- Publication date Sep 5, 2013
- Domantis Limited
- Steven Holmes
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compositions and Methods for Treating Inflammatory Disorders
- Publication number 20130216538
- Publication date Aug 22, 2013
- Domantis Limited
- Olga Ignatovich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DUAL-SPECIFIC IL-1A/ IL-1B ANTIBODIES
- Publication number 20130171146
- Publication date Jul 4, 2013
- Abbott Laboratories
- Chung-ming Hsieh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS MONOVALENT FOR CD28 BINDING AND METHODS OF USE
- Publication number 20130109846
- Publication date May 2, 2013
- Domantis Ltd.
- Murray McKinnon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L
- Publication number 20130095109
- Publication date Apr 18, 2013
- Domantis Limited
- Steven G. NADLER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS MONOVALENT FOR CD28 BINDING AND METHODS OF USE
- Publication number 20120201814
- Publication date Aug 9, 2012
- Domantis Ltd.
- Murray McKinnon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS MONOVALENT FOR CD40L BINDING AND METHODS OF USE
- Publication number 20110172400
- Publication date Jul 14, 2011
- Domantis Limited
- Steven Grant
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compositions monovalent for CD28 binding and methods of use
- Publication number 20110097339
- Publication date Apr 28, 2011
- Domantis Limited
- Steven Holmes
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compositions monovalent for CD40L binding and methods of use
- Publication number 20100092483
- Publication date Apr 15, 2010
- Domantis Limited
- Steven Grant
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compositions monovalent for CD40L binding and methods of use
- Publication number 20100092482
- Publication date Apr 15, 2010
- Domantis Limited
- Steven Grant
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Ligand
- Publication number 20100081792
- Publication date Apr 1, 2010
- SmithKline Beecham Corporation
- Steven Grant
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS MONOVALENT FOR CD28 BINDING AND METHODS OF USE
- Publication number 20100028354
- Publication date Feb 4, 2010
- Bristol-Myers Squibb Company
- Murray McKinnon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions monovalent for CD40L binding and methods of use
- Publication number 20090297524
- Publication date Dec 3, 2009
- Steven Grant
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Dual-specific IL-1A/IL-1b antibodies
- Publication number 20090291081
- Publication date Nov 26, 2009
- Chung-Ming Hsieh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY DISORDERS
- Publication number 20090258012
- Publication date Oct 15, 2009
- Domantis Limited
- Olga Ignatovich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and methods for treating inflammatory disorders
- Publication number 20060073141
- Publication date Apr 6, 2006
- Domantis Limited
- Olga Ignatovich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions monovalent for CD40L binding and methods of use
- Publication number 20060062784
- Publication date Mar 23, 2006
- Domantis Limited
- Steven Grant
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compositions and methods for treating inflammatory disorders
- Publication number 20050271663
- Publication date Dec 8, 2005
- Domantis Limited
- Olga Ignatovich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Steven Grant

Person

Patents Grantslast 30 patents

Compositions monovalent for CD28 binding and methods of use

Antibody polypeptides that antagonize CD40L

Methods of treating immune diseases by administering antibody polyp...

Compositions monovalent for CD28 binding and methods of use

Nucleic acids encoding antibody polypeptides that antagonize CD40

Methods of treating immune diseases by administering antibody polyp...

Compositions monovalent for CD28 binding and methods of use

Antibody polypeptides that antagonize CD40L

Antibody polypeptides that antagonize CD40

Antibody polypeptides that antagonize CD40L

Anti P2X7 receptor antibodies and fragments thereof

Compositions monovalent for CD28 binding and methods of use

Nucleic acids encoding antibody polypeptides that antagonize CD40L

Antibody polypeptides that antagonize CD40L

Methods of antagonizing the binding of CD40 to CD40L with CD40L-spe...

Compositions monovalent for CD28 binding and methods of use

Dual-specific IL-1α/IL-1β antibodies

Compositions monovalent for CD28 binding and methods of use

Antibodies against Candida antigens

Methods of antagonizing binding of CD40 to CD40L with CD40L-specifi...

CD40L-specific monovalent polypeptides

Monovalent anti-CD40L antibody polypeptides and compositions thereof

Patents Applicationslast 30 patents

ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L

COMPOSITIONS MONOVALENT FOR CD28 BINDING AND METHODS OF USE

METHODS OF TREATING IMMUNE DISEASES BY ADMINISTERING ANTIBODY POLY...

ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L

ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L

ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40

ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L

COMPOSITIONS MONOVALENT FOR CD28 BINDING AND METHODS OF USE

ANTI P2X7 RECEPTOR ANTIBODIES AND FRAGMENTS THEREOF

ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L

ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L

ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40

COMPOSITIONS MONOVALENT FOR CD28 BINDING AND METHODS OF USE

Compositions and Methods for Treating Inflammatory Disorders

DUAL-SPECIFIC IL-1A/ IL-1B ANTIBODIES

COMPOSITIONS MONOVALENT FOR CD28 BINDING AND METHODS OF USE

ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L

COMPOSITIONS MONOVALENT FOR CD28 BINDING AND METHODS OF USE

COMPOSITIONS MONOVALENT FOR CD40L BINDING AND METHODS OF USE

Compositions monovalent for CD28 binding and methods of use

Compositions monovalent for CD40L binding and methods of use

Compositions monovalent for CD40L binding and methods of use

Ligand

COMPOSITIONS MONOVALENT FOR CD28 BINDING AND METHODS OF USE

Compositions monovalent for CD40L binding and methods of use

Dual-specific IL-1A/IL-1b antibodies

COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY DISORDERS

Compositions and methods for treating inflammatory disorders

Compositions monovalent for CD40L binding and methods of use

Compositions and methods for treating inflammatory disorders